Thomas Equels bought $5K of AIM ImmunoTech stock

By AlphaYouPublished Oct 26, 2026Form 4

Stocks in this disclosure

Reported activity

Equels Thomas K

Reporting filer

Thomas Equels reported buying 31,675 shares of AIM ImmunoTech Inc. for about $5K ($0.16 a share on average). Form 4 filed Oct 26, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Equels Thomas K	2026-10-23	P	Purchase	31675	0.160	189,747	3 days	Filed terms security Title: Common Stock transaction Date: 2026-10-23 deemed Execution Date: transaction Form Type: 4 transaction Code: P equity Swap Involved: 0 transaction Timeliness: transaction Shares: 31675 transaction Price Per Share: 0.160 transaction Acquired Disposed Code: A shares Owned Following Transaction: 189747 direct Or Indirect Ownership: D

Owner: Equels Thomas K
Date: 2026-10-23
Code: P
Action: Purchase
Quantity: 31675
Price: 0.160
Following holdings: 189,747
Reporting delay: 3 days
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-23
deemed Execution Date:
transaction Form Type: 4
transaction Code: P
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 31675
transaction Price Per Share: 0.160
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 189747
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Equels Thomas K: CEO & President, Director.

Prepared automatically from public filing data. Report a correction.